Industry Analysis & Industry Trends
Due to rising demand for industry products, and historic inaccessibility to a number of high-quality human biospecimens, the Cryogenic Biobanking Services industry has performed exceptionally well over the five years to 2013. While industry operators have faced a number of challenges over this period, particularly with regard to funding, rising research and development expenditure and the mounting importance disease researchers place on biospecimens, the industry continued to grow rapidly.... purchase to read more
Industry Report - Industry SWOT Analysis Chapter
The Cryogenic Biobanking Services industry is in the growth stage of its economic life cycle. This stage is characterized by rapid increases in enterprise figures, an evolving technological landscape and growing acceptance of industry services by downstream researchers. Industry value added (IVA), which measures an industry's contribution to the overall economy, is expected to increase at an annualized rate of 14.0% during the 10 years to 2018. In contrast, US GDP is projected to grow at an annualized rate of 2.1% during the same period. Typically, an industry is considered to be in the growth phase of its life cycle when industry development exceeds that of the overall economy over a 10-year period... purchase to read more